Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Expensive Underperformer
989.1000
-11.40
(
-1.14
%)
NSE
Apr 17, 2025
15:31 PM
25.92% Fall from 52W High
Volume:
98,417
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
29 Apr 2024
989.10
-1.14%
Glenmark Life Science
Buy:
Alivus Life Sciences Ltd.
by
ICICI Direct
Target: 1040 | Target met
ICICI Direct
Alivus Life Sciences Ltd. is trading below all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - April 17, 2025
The Baseline |
17 Apr 2025
Market closes higher, HDFC AMC's net profit beats Forecaster estimates by 8%
Trendlyne Marketwatch |
17 Apr 2025
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021